Skip to content

Evaluation of the Effects of Osteoperforation and Piezocorticision on Canine Retraction

Evaluation of the Effects of Osteoperforation and Piezocorticision on Canine Retraction: Randomized Controlled Clinical Trial.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03308851
Enrollment
17
Registered
2017-10-13
Start date
2018-01-01
Completion date
2021-04-30
Last updated
2021-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Canine Retraction, Orthodontic Treatment, Osteoperforation, Piezocorticision

Brief summary

The primary objective of this research is to compare the rate of canine retraction following the osteoperforation and piezocorticision procedures in cases of first premolar extractions. The secondary objectives are to compare the second order movement of the canine (tipping), the amount of root resorption associated with the procedures, the inflammation process by measuring the inflammatory markers in the gingival crevicular fluid, the loss of posterior anchorage by measures on the cone beam computed tomography (CBCT) 3-dimensional radiograph and on the casts and to evaluate the pain level and the impact on quality of life following each procedure using the questionnaire of the visual analogue scale (VAS) of pain.

Interventions

PROCEDUREPiezocorticision

The piezocorticision is a procedure that aims to accelerate the movement of teeth during an orthodontic treatment. It consists of a local anaesthesia followed by an incision of the buccal mucosa and an incision in the alveolar bone with a piezotome.

PROCEDUREOsteoperforation

The osteoperforation is a procedure that aims to accelerate the movement of teeth during orthodontic treatment. It consists of a local anaesthesia followed by perforations of the buccal mucosa and alveolar bone using a specific osteoperforation tool.

Sponsors

University of Michigan
CollaboratorOTHER
Université de Montréal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A split mouth design will be used where the experimental subjects will receive one procedure on one side of the upper dental arch and another procedure on the other side.

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Dental and/or skeletal Cl I and II requiring maxillary first premolar extraction. * Young adults 16 years and older. * Good overall health. * Complete adult dentition. * Cooperative. * Acceptable hygiene. * Absence of any periodontal disease (gingivitis, periodontitis).

Exclusion criteria

* Non-cooperative, fearful patients or patients with intellectual disability. * Patients requiring the regular use of nonsteroidal anti-inflammatory drugs (NSAID). * Use of antibiotics in the last 6 months. * Previous or current use of bisphosphonates, corticosteroids or immunosuppressive drugs. * Smokers. * Patients suffering from uncontrolled systemic diseases (ex. diabetes type I and II). * Presence of oral or maxillofacial malformations (ex. cleft palate) or dental pathologies (ex. ankylosis, abscess).

Design outcomes

Primary

MeasureTime frameDescription
Rate of canine retractionFrom the time of force application until the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeks. Measures will be taken at two week intervals.The speed at which the canine is moved in the space of the extracted premolar.

Secondary

MeasureTime frameDescription
Concentration of osteoprotegerin (OPG) in the gingival fluid sampleMeasures are taken immediately before the periodontal procedures, then at 1,3,8 weeks and when the distal of the canine touches the mesial surface of the second premolar which can take up to 24 weeks.Measure of the concentration of OPG using the Luminex technique.
Amount of tippingThe measure is taken when the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeksThe angulation of the long axis of the canine at the end of the retraction.
Amount of root resorptionThe measure is taken when the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeksThe total reduction in volume of the root of the canine caused by the canine retraction measured on the cone beam computed tomography.
Level of painDaily, for 7 days following extraction of premolars and piezocorticision and osteoperforation proceduresMeasure of the level of pain using a visual analogue scale of pain questionnaire ranging from 0-10.
Concentration of IL-1 in the gingival fluid sampleMeasures are taken immediately before the periodontal procedures, then at 1,3,8 weeks and when the distal of the canine touches the mesial surface of the second premolar which can take up to 24 weeks.Measure of the concentration of IL-I using the Luminex technique.
Concentration of receptor activator of nuclear factor kappa-B ligand (RANKL) in the gingival fluid sampleMeasures are taken immediately before the periodontal procedures, then at 1,3,8 weeks and when the distal of the canine touches the mesial surface of the second premolar which can take up to 24 weeks.Measure of the concentration of RANKL using the Luminex technique.
Amount of posterior loss of anchorageThe measure is taken when the distal of the canine touches the mesial of the second premolar. We estimate the time frame to be up to 24 weeksMeasure of the amount of anterior movement of the posterior teeth during the retraction of the canine.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026